Beyond whole blood and its components are a range of treatments that individual Jehovah's Witnesses may accept or not. Simon Etches, Jehovah's Witness hospital liaison committee member for Nottingham, describes them as 'conscience issues' that are not clearly prohibited. They include: 2 • blood derivatives such as platelet fractions, cryoprecipitate, albumin, immunoglobulins, haemoglobin and interferons • recombinant erythropoietin and recombinant factor VIIa • procedures such as intraoperative cell salvage and acute normovolaemic haemodilution
These treatments, where appropriate, may mitigate some of the risks, especially of elective surgery. Many Jehovah's Witness patients have completed an advance decision document, which they carry for use in an emergency and to inform treatment planning before elective surgery. These signed and witnessed documents set out which specific treatments they find acceptable. Their use is encouraged but 'not obligatory', says Mr Etches.
lEGAl POSITION AND GUIDANCE
Legally, patients have a clear right to refuse treatment as long as they are competent to do so. Competence is assessed in line with the 2005 Mental Capacity Act, which explicitly states: 'A person is not to be treated as unable to make a decision merely because he makes an unwise decision'.
3 This is re-emphasised in the National Institute for
Health and Care Excellence guideline on decision making and mental capacity published in 2018.
4
Advance decisions to refuse life-sustaining treatment must be documented, signed and witnessed, and can only be made by people aged 18 years and over. 4 A valid, applicable advance decision is legally binding so surgeons must abide by the document unless the patient has changed his or her mind, or does not have capacity to consent and has appointed someone with a lasting power of attorney since the document was signed. Advance decisions apply only to refusal of treatment; no one can insist on having a treatment. If a situation were to arise where a surgeon felt that the risks of performing a procedure under the restrictions placed on it by a patient outweighed the benefits, the surgeon could not be compelled to operate.
The refer patients to a doctor who is qualified and prepared to take on the patient in these circumstances. Children under 18 years of age cannot make legally binding advance decisions although under-16s judged to have competency to make or withhold consent for treatment can do so. NHS trusts can obtain court orders to overrule the refusal of life-sustaining or life-saving procedures by children or their parents.
In an emergency, where there is insufficient time to obtain a court order, the clinician must act in the best interests of the child -which may include administering a blood transfusion. However, 'every effort must be made to respect the beliefs of the family and avoid the use of blood or blood products wherever possible'. have already lost blood into tissue. In other operations, the small amount of expected blood loss means 'a lot of fuss and you end up giving back a bit of a dribble', says Dr Wallis.
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OPTIMISATION AND MITIGATION OF RISK
Cell salvage adds complexity to a procedure but Dr Wallis notes that if it's done routinely, it's not so much of a problem. Jehovah's Witnesses undergoing surgery where blood loss is expected 'should go to a unit that does that sort of surgery all the time', he says.
ClINICAl JUDGEMENT
'If you're going to do something where you anticipate blood is going to be needed and the patient says "I'm not having blood", you ' Professor Dileep Lobo, professor of gastrointestinal surgery at the University of Nottingham, says that although 'cell salvage can save life', it does not completely mitigate risk because you can only give back what is captured and it doesn't help if a patient haemorrhages postoperatively. 'I would be very reluctant to operate without the possibility of cell salvage. We are trying to extend the patient's life. We don't want to get into a situation where the operation kills the patient. ' Professor Lobo says decisions must be based on the balance of probabilities. 'For my own practice, with pancreatic cancer, some are resectable and some are borderline. With [borderline cases], it's not worth taking the risk.' He points to the potential impact, not just on the patient but also on the treating team. 'We're all trained to save lives and make operations as safe and easy as possible. You can't legislate for unexpected bleeding. For the team, it's very difficult to accept if you have a situation where the patient dies from blood loss and you have no opportunity to save the patient's life.'
VAlID CONSENT
In order to provide valid consent, a patient must not be subject to undue influence or coercion. 4 Clearly, clinicians must be careful that the provision of information does not spill over into undue influence. In addition, if a clinician feels that a patient may be under pressure from family or faith representatives, the clinician should see the patient alone, to be sure the patient is happy with the decision. As well as having capacity to make the decision (and making it free from undue influence), the patient must understand the options available, and the benefits and risks attached to them. Given that different Jehovah's Witness patients may have differing views about the acceptability of certain blood products or derivatives, it is advisable to use a checklist that asks explicitly about the different treatment options, and also to ask about specific circumstances.
1 For example, do they wish not to receive blood products even if their life may be at imminent risk if these are not given?
The consent process should usually be guided by the surgeon who plans to carry out the procedure although haematologists may have a role in explaining and asking for consent for specific interventions, such as preoperative treatments to optimise haemoglobin.
UNClEAR CONSENT
Difficulties are most likely to arise if consent is unclear. The local Hospital Liaison Committee for Jehovah's Witnesses (HLC) may be able to help if patients are confused about which treatments are or are not acceptable, or if patients want help in making the decision. Mr Etches says that HLC members receive rigorous training to ensure they do not exercise undue influence while helping to explain treatments and their status to patients. 'It doesn't matter to us what the decision is; it matters that they are supported in the decision making process', he says. The HLC may also be helpful when reassurance is required, such as if a patient is uncertain or suspicious that a non-blood product is actually blood-derived.
Emergency situations, where a patient is unable to provide consent (and where there is no valid, written advance directive) but there are strong grounds to believe the patient is a Jehovah's Witness, pose perhaps the greatest challenge. If a friend or relative insists that an unconscious patient, with a condition that would usually require transfusion, would not want transfusion, what is the treating team to do?
General Medical Council guidance is clear that emergency treatment to save life or prevent deterioration can be provided in the absence of consent. 6 The RCS guidance says that in such a situation 'every effort should be made to avoid the use of blood and blood products [...] However, in serious or life-threatening situations the use of blood and blood products should be based on the judgement of the clinician responsible'. Nevertheless, should blood products be used, the decision making process should be documented, and the clinical teams' actions and reasons for acting should be explained to the patient subsequently.
1
CONClUSION
While there is no doubt that refusal of blood products can create clinical and ethical challenges, much can now be done to streamline the process and optimise the situation, at least in an elective setting. Dr Wallis believes that treating Jehovah's Witness patients has 'helped focus our minds on avoiding blood loss and looking at alternatives to transfusion'.
Mr Lamont, however, says that there are 'all sorts of drivers' to reduce blood loss in surgery. While he is sceptical that Jehovah's Witness patients have advanced the field, he notes that research into avoiding bank blood has been beneficial for Jehovah's Witnesses.
Despite this, the challenge in emergency situations remains unresolved. 'It would be extremely difficult to accept if a patient died from blood loss and we had no opportunity to save the patient's life', says Professor Lobo. 'We don't give transfusions without thinking hard about them, but [transfusion] is there to save life.'
